Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients

Circulation

Volumn 97, Issue 1, 1998, Pages 66-74

  Schaumann, Anselm ^a   Von zur Mühlen, Friederike ^b   Herse, Bernhard ^b   Gonska, Bernd Dieter ^b   Kreuzer, Heinrich ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NONE

Author keywords

Arrhythmia; Heart assist device; Pacing; Tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TACHYCARDIA; TREATMENT OUTCOME;

EID: 0031964138     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.1.66     Document Type: Article

References (28)

1. Nisam S, Breithardt G. Mortality trials with implantable defibrillators. Am J Cardiol. 1997;79:468-471.
2. Leitch JW, Gillis AM, Wyse DG, Yee R, Klein GJ, Guiraudon G, Sheldon RS, Duff HJ, Kieser TM, Mitchell LB. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol. 1991;18:145-151.
3. Mitra RL, Hsia HH, Hook BG, Callans DJ, Flores BT, Miller JM, Josephson ME, Marchlinski FE. Efficacy of antitachycardia pacing in patients presenting with cardiac arrest. Pacing Clin Electrophysiol. 1995;18: 2035-2040.
4. Saksena S, Poczobutt-Johanos M, Castle LW, Fogoros RN, Alpert BL, Kron J, Pacifico A, Griffin J, Ruskin JN, Kehoe RF, Yee R, Dorian P, Kerr CR, Luceri RM, Poliseno M. Longterm multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 1992;19: 490-499.
5. Bardy GH, Troutman C, Poole JE, Kudenchuk PJ, Dolack GL, Johnson G, Hofer B. Clinical experience with a tiered-therapy multiprogrammable antiarrhythmia device. Circulation. 1992;85:1689-1698.
6. Estes M, Haugh CJ, Wang PF, Manolis AS. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective. Am Heart J. 1994;127:1038-1046.
7. Rosenquist M. Pacing techniques to terminate ventricular tachycardia. Pacing Clin Electrophysiol. 1995;18:592-598.
8. Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack L, Gleva M, Mitchell R, Kelso D. Implantable transvenous cardioverter-defibrillators. Circulation. 1993;87:1152-1168.
9. Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, Dulk den K, Coumel P, Camm AJ, Touboul P. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Circulation. 1992;86:363-374.
10. Porterfield JG, Porterfield LM, Smith BA, Bray L, Voshage L, Martinez A. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. Pacing Clin Electrophysiol. 1993; 16:170-173.
11. Wietholt D, Block M, Isbruch F, Böcker D, Borggrefe M, Shenasa M, Breithardt G. Clinical experience with antitachycardia pacing and improved detection algorithms in a new cardioverter-defibrillator. J Am Coll Cardiol. 1993;21:885-894.
12. Schaumann A, Von zur Mühlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol. 1996;78:42-50.
13. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ. Classification of death in antiarrhythmia trials. J Am Coll Cardiol. 1996;27:433-442.
14. Gross JN, Sackstein RD, Song SL, Chang CJ, Kawinishi DT, Furman S. The antitachycardia pacing ICD: impact on patient selection and outcome. Pacing Clin Electrophysiol. 1993;16:165-169.
15. Mitchell JD, Lee R, Garan H, Ruskin JN, Torchiana DF, Vlahakes GJ. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy. J Thorac Cardiovasc Surg. 1993;105:453-463.
16. Wood MA, Stambler BS, Damiano RJ, Greenway P, Ellenbogen KA. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. J Am Coll Cardiol. 1994;24:1692-1699.
17. Siebels J, Jörgensen M, Schneider MAE, Kuck KH. Effektivität antitachykarder Stimulation im implantierten Cardioverter/Defibrillator: Nutzen oder Risiko. Z Kardiol. 1991;80:521. Abstract.
18. Heisel A, Neunzer J, Himmrich E, Pitschner HF, Liebrich A, Jung J, Sen S. Safety of antitachycardia pacing in patients with implantable cardioverter defibrillators and severely depressed left ventricular function. Pacing Clin Electrophysiol. 1995; 18:137-141
19. Trappe HJ, Klein H. Kielblock B. Role of antitachycardia pacing in patients with third generation cardioverter defibrillators. Pacing Clin Electropliysiol. 1994;17:506-513.
20. Trappe HJ, Pfitzner P, Hemtze J. Kielblock B, Wenzlaff P, Fieguth HG, Klein H. Die Bedeutung der antitachykarden Stimulation bei Patienten mit Defibrillatoren der 3. Generation. Z Kardiol. 1995;84:35-43.
21. Böcker D, Block M, Isbruch F, Fastenrath C, Castrucci M, Hammel D, Scheld HH, Borggrefe M, Breithardt G. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J. 1993;73:158-163.
22. Gillis AM, Leitch JW, Sheldon RS, Morillo CA, Wyse DG, Klein GJ, Mitchell LB. A prospective randomized comparison of autodecremental pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1993;72:1146-1151.
23. Hook BG, Callans DJ, Kleiman RB, Flores BT, Marchlinski FE. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms: rhythm diagnosis and management aided by stored electrogram analysis. Circulation. 1993;87:1897-1906.
24. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter/defibrillators. Pacing Clin Electrophysiol. 1992; 15:1667-1673.
25. Grimm W, Flores BF, Marchlinski FE. Complications of implantable cardioverter defibrillator therapy: follow-up of 241 patients. Pacing Clin Electrophysiol. 1993;16:218-222.
26. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter defibrillator. J Am Coll Cardiol. 1994;23: 1342-1355.
27. Schmitt C, Brachmann J, Saggau W, Beyer T, Waldecker B, Scharowski K, Hilbel T, Montero M, Offner B, Schöls W, Kübier W. Kombinierte antitachykarde/antibradykarde Schrittmacher-Kardioverter-Defibrillator-Systeme bei Patienten mit rezidivierenden ventrikulären Tachyarrhythmien. Z Kardiol. 1991;80:665-672.
28. Calkins H, Haugh CJ, Wang PF, Manolis AS. Comparison of fixed burst versus decremental burst pacing for ventricular tachycardia. Pacing Clin Electrophysiol. 1993;16:26-32